Literature DB >> 2234831

Prevalence of Meibomian gland dysfunction.

M M Hom1, J R Martinson, L L Knapp, J R Paugh.   

Abstract

This study was performed to determine the prevalence of Meibomian gland dysfunction (MGD) and to determine which patient profile factors might be associated with the syndrome. Patients were randomly selected, apparently normal patients presenting for routine vision examinations. Of the 398 patients for whom Meibomian gland expression was performed and a detailed history obtained, 155 patients or 38.9% exhibited MGD based on the principal clinical criterion of an absent or cloudy Meibomian gland secretion upon expression. Patient profile factors of gender, age, allergy occurrence, and contact lens wear were analyzed for correlation with MGD. Age was found to be the only significant correlating factor (positive correlation, p less than 0.0001).

Entities:  

Mesh:

Year:  1990        PMID: 2234831     DOI: 10.1097/00006324-199009000-00010

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  36 in total

1.  The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy.

Authors:  Yukihiro Matsumoto; Yuta Shigeno; Enrique Adan Sato; Osama M A Ibrahim; Megumi Saiki; Kazuno Negishi; Yoko Ogawa; Murat Dogru; Kazuo Tsubota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-20       Impact factor: 3.117

Review 2.  Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD).

Authors:  Ho Sik Hwang; Geraint J Parfitt; Donald J Brown; James V Jester
Journal:  Exp Eye Res       Date:  2017-02-17       Impact factor: 3.467

3.  [Meibomian glands : part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD)].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

Review 4.  The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.

Authors:  Alan Tomlinson; Anthony J Bron; Donald R Korb; Shiro Amano; Jerry R Paugh; E Ian Pearce; Richard Yee; Norihiko Yokoi; Reiko Arita; Murat Dogru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 5.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 6.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

7.  Eyelid cleansing with ointment for obstructive meibomian gland dysfunction.

Authors:  Minako Kaido; Osama M A Ibrahim; Motoko Kawashima; Reiko Ishida; Enrique A Sato; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2016-10-03       Impact factor: 2.447

8.  Effects of age and dysfunction on human meibomian glands.

Authors:  Chyong Jy Nien; Salina Massei; Gloria Lin; Cameron Nabavi; Jeremiah Tao; Donald J Brown; Jerry R Paugh; James V Jester
Journal:  Arch Ophthalmol       Date:  2011-04

9.  Azithromycin in DuraSite for the treatment of blepharitis.

Authors:  Jodi Luchs
Journal:  Clin Ophthalmol       Date:  2010-07-30

10.  [Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye].

Authors:  E Knop; N Knop; H Brewitt; U Pleyer; P Rieck; B Seitz; F Schirra
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.